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SENDAZAC DECREASES IN VITRO GLYCATION OF HUMAN LENS 
CRYSTALLINS 
MARQUES C.. RAMALHO J.S., PEREIRA I’. and MOTA M.C. 
Biimedtoal lnstiiute for Research in Lght a!?d Image. Coinbra University Hospitals, 
Portugal. 
Purpose. Bendazao has been used as an anticataraotogenic drug. It has been 
repotted that this sots by preventing protein denaturation. In this study the ability d 
‘bendazac to inhibit in vitro glyoatlln ot hum;,n lens crystallinswas evakrated. 
Methods. Possible effects of bendazac: were detected by incubation of WS 
crystallins with the reducing sugars glucose and truotose. The efficiency of 
bendazac was evaluated by means of selected parameters including: browning, 
glyoation (measured as iurosine mntent) and speoilii NTP-fluoresoence. 
ResuIts. The results showed clearly that bendazac (bendarac L-lysine and 
sodiim) inhibits the early stages of protein glyoation, as well as the formation of 
fluorescent advanced glycation products. Sendazac lysine (20 mM) proved to be 
more efteaive in inhibiting lluorescencs development (67% inhibition) than the 
corresponding sodium satl (35% inhiblion). No significant ditierencas were found 
with respect to lurosine levels; about 40% inhibition was produced with either 
bendazac lysine or sodium salt. 
ConclusldnS. Sendazac clearly inhibits glycatiin 01 human lens crystallins, as can 
be ettlliently monitored by following spedic changes in lens protein lluorescence. 
These results may constitute a new and relevant therapeutic approach to 
monitoring cataract development. 
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MECHAHISMS INVOLVED IN UV-A DANAGE TO THE EYE LENS 
DOVNAT A. and YEINREB 0. 
Faculty of Medicine, Technion-Israel Institute of Technology. 
Haifa, ISRAEL. 
Purpose: To investigate the mechanisms involved in the damage 
caused by UV-A radiation on the aye lens. 
Methods. Bovine lenses obtained from animals 2-3 years old were - 
placed in specially designed culture cells for pre-incubation of 
24h. The lenses were oriented so that the anterior surface faced 
the incident UV-A radiation source and were maintained in the 
cells during irradiation. After irradiation, lens optical 
quality was monitored throughout the culture period and lens 
epithelium, cortex and nuclear samples were taken for 
biochemical analysis. 
Results: There is almost no change in the focal length 
variability (sharpness of focus) of the control lenses 
throughout the 9 days of the culture period. Irradiated lenses 
at levels of 25J/cm2 to 35J/cm2 of UV-A, demonstrated an 
increase in focal length variability 72 to 96 hours after 
irradiation. 46 to 96 hours later focal length variability 
returned to control levels. Damage to several lens epithelial 
enzymes appears before the optical damage. Transglutaminase 
activity in lens epithelium was not affected by UV-A radiation. 
However, the cross-linking enzyme in the lens cortex and nucleus 
was activated as a result of the irradiation and returned to 
control levels a few days later, at which time the lens 
recovered from the irradiation damage. 
Conclusions: It appears that transglutaminase is involved in the 
mechanism by which UV-A causes damage to the eye lens. 
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